Journal of neurosurgical sciences最新文献

筛选
英文 中文
Transvenous Onyx embolization for dural arteriovenous fistula with concomitant transvenous balloon protection of the venous sinus. 经静脉缟玛瑙栓塞治疗硬脑膜动静脉瘘,同时经静脉球囊保护静脉窦。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2020-04-29 DOI: 10.23736/S0390-5616.20.04937-1
Xianzeng Tong, Ming Ye, Jingwei Li, Peng Hu, Tao Hong, Peng Zhang, Hongqi Zhang
{"title":"Transvenous Onyx embolization for dural arteriovenous fistula with concomitant transvenous balloon protection of the venous sinus.","authors":"Xianzeng Tong, Ming Ye, Jingwei Li, Peng Hu, Tao Hong, Peng Zhang, Hongqi Zhang","doi":"10.23736/S0390-5616.20.04937-1","DOIUrl":"10.23736/S0390-5616.20.04937-1","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to evaluate the technical efficacy and safety of transvenous Onyx embolization for dural arteriovenous fistulas (DAVFs) with concomitant transvenous balloon protection of the venous sinus when transarterial route failed or was not feasible.</p><p><strong>Methods: </strong>Between September 2010 and December 2016, thirty-six patients presenting with intracranial DAVFs underwent transvenous balloon-assisted Onyx embolization. The technical efficacy, treatment-related complications, and angiographic and clinical outcomes were reviewed from our prospectively maintained DAVF database.</p><p><strong>Results: </strong>According to the Cognard Classification, 11 patients presented with clinically symptomatic Cognard type I; 11 cases with Cognard type IIa; 10 cases with Cognard type IIb; and 4 cases with Cognard type IIa+b. Complete angiographic occlusion of the DAVFs at the latest follow-up (mean 18 months after transvenous embolization) was achieved in 28 patients (77.8%), near-complete angiographic occlusion with minimal residual fistula in 5 patients (13.9%) and significant flow reduction of the DAVF in 2 patients (5.6%) and residual fistula for further treatment in 1 (2.8%) patient. Total clinical cure or remission of the pretreatment symptoms was achieved in 31 patients (31/36, 86.1%; 26 and 5 cases respectively). Affected venous sinus was preserved in 28 patients, intentionally occluded in 7 patients and gradually occluded in 1 patient. There were no immediate or long-term persistent complications after treatment.</p><p><strong>Conclusions: </strong>Transvenous Onyx embolization of dural arteriovenous fistulas with combined transvenous balloon protection of the venous sinus is safe and effective in achieving high occlusion rate, low embolization-related complications and satisfactory clinical outcomes.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"89-100"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37883372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancement of miR-16-5p on spinal cord injury-induced neuron apoptosis and inflammatory response through inactivating ERK1/2 pathway. miR-16-5p 通过抑制 ERK1/2 通路增强脊髓损伤诱导的神经元凋亡和炎症反应。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2020-02-10 DOI: 10.23736/S0390-5616.20.04880-8
Qian-Cheng Zhao, Zhe-Wei Xu, Qing-Ming Peng, Jia-Hui Zhou, Zhi-Yue Li
{"title":"Enhancement of miR-16-5p on spinal cord injury-induced neuron apoptosis and inflammatory response through inactivating ERK1/2 pathway.","authors":"Qian-Cheng Zhao, Zhe-Wei Xu, Qing-Ming Peng, Jia-Hui Zhou, Zhi-Yue Li","doi":"10.23736/S0390-5616.20.04880-8","DOIUrl":"10.23736/S0390-5616.20.04880-8","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to explore the effect and mechanism of miR-16-5p on neuron apoptosis and inflammatory response induced by spinal cord injury (SCI).</p><p><strong>Methods: </strong>Allen's weight-drop method and Basso Bcattie Bresnahan (BBB) rating scale were used to establish SCI rat model and assess locomotor function, respectively. Histopathology of SCI rats and Sham-operated rats was validated by hematoxylin and eosin (H&E) staining. After intravenous injection of miR-16-5p agomir, miR-16-5p antagomir, pcDNA3.1-Apelin-13 or negative controls into SCI rat tails, neuron apoptosis and the expression of miR-16-5p, Apelin-13, apoptotic proteins, inflammatory response-related proteins, and ERK1/2 pathway-related protein were detected. Dual luciferase reporter gene assay was applied for identifying the binding between miR-16-5p and Apelin-13.</p><p><strong>Results: </strong>SCI rats had locomotor impairment with markedly edema and hemorrhage. Upregulated miR-16-5p expression and downregulated Apelin-13 expression were presented in SCI rats. Intravenous injection of miR-16-5p antagomir or/and pcDNA3.1-Apelin-13 could increase the expression of antiapoptotic proteins (Bcl-2 and Mcl-1) and p-ERK1/2 expression while decrease the expression of proapoptotic proteins (cleaved caspase-3 and Bax) and inflammatory response-related proteins (TNF-α, IL-1β and IL-6). The reverse pattern was shown in rats injected with miR-16-5p agomir. MiR-16-5p targeted Apelin-13. Promotion of miR-16-5p agomir on SCI was attenuated by injection of agomir + pcDNA3.1-Apelin-13.</p><p><strong>Conclusions: </strong>Downregulation of miR-16-5p could upregulate Apelin-13 expression to activate ERK1/2 pathway, thus alleviating SCI-induced neuron apoptosis and inflammatory response.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"101-108"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37632125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of rehabilitation nursing based on target management theory on swallowing function and Quality of Life in patients with stroke dysphagia. 基于目标管理理论的康复护理对脑卒中吞咽困难患者吞咽功能和生活质量的影响
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2023-09-05 DOI: 10.23736/S0390-5616.23.06087-3
Chenya Yu, Jiong Wu, Susu Yu
{"title":"Effect of rehabilitation nursing based on target management theory on swallowing function and Quality of Life in patients with stroke dysphagia.","authors":"Chenya Yu, Jiong Wu, Susu Yu","doi":"10.23736/S0390-5616.23.06087-3","DOIUrl":"10.23736/S0390-5616.23.06087-3","url":null,"abstract":"","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"140-142"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10152023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis. 创伤性脑损伤中的颅内压监测器插入:单中心回顾性决策过程分析。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2018-11-08 DOI: 10.23736/S0390-5616.18.04568-X
Francesca Fossi, Chiara Robba, Matteo Rota, Alessia Vargiolu, Doriana Lagravinese, Paola Volpi, Giuseppe Citerio
{"title":"Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis.","authors":"Francesca Fossi, Chiara Robba, Matteo Rota, Alessia Vargiolu, Doriana Lagravinese, Paola Volpi, Giuseppe Citerio","doi":"10.23736/S0390-5616.18.04568-X","DOIUrl":"10.23736/S0390-5616.18.04568-X","url":null,"abstract":"<p><strong>Background: </strong>Evidence-based indications for intracranial pressure (ICP) monitoring in patients with traumatic brain injury (TBI) are lacking. The aim of this study was to analyze the main factors that guided the decision-making of invasive ICP monitoring in a large cohort of TBI patients from our institution.</p><p><strong>Methods: </strong>This is a retrospective, single centre, observational study including adult TBI patients consecutively admitted to our Neurointensive Care Unit over 20 years. Logistic regression analyses were performed to identify potential factors associated with the decision for ICP monitor insertion. A decision tree was developed to identify the combination of factors with the highest statistical power to predict the decision for ICP monitor insertion.</p><p><strong>Results: </strong>A total of 857 adult patients were included in the analysis. The decision to monitor ICP was strongly related to different factors, including Glasgow Coma Scale (GCS), computed tomography (CT) scan classification, pupils' reactivity, and patients' prognosis at the admission calculated by the International Mission on Prognosis in Traumatic Brain Injury (IMPACT) score (P<0.01). Results from the decision tree showed an overall ability of the 72% in the prediction of ICP monitoring and that, among the factors analyzed, CT findings had the primarily and strongest discrimination power.</p><p><strong>Conclusions: </strong>The decision to insert an invasive ICP monitoring in patients with TBI is multifactorial. Among the different factors analysed in our cohort of TBI patients, prognostication factors as for IMPACT score and in particular CT findings could potentially explain the decision making for ICP monitoring.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"51-58"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36659429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative computed tomography, navigated ultrasound, 5-amino-levulinic acid fluorescence and neuromonitoring in brain tumor surgery: overtreatment or useful tool combination? 脑肿瘤手术中的术中计算机断层扫描、导航超声、5-氨基乙酰丙酸荧光和神经监测:过度治疗还是有用的工具组合?
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2019-07-11 DOI: 10.23736/S0390-5616.19.04735-0
Giuseppe M Barbagallo, Massimiliano Maione, Simone Peschillo, Francesco Signorelli, Massimiliano Visocchi, Giuseppe Sortino, Giuseppa Fiumanò, Francesco Certo
{"title":"Intraoperative computed tomography, navigated ultrasound, 5-amino-levulinic acid fluorescence and neuromonitoring in brain tumor surgery: overtreatment or useful tool combination?","authors":"Giuseppe M Barbagallo, Massimiliano Maione, Simone Peschillo, Francesco Signorelli, Massimiliano Visocchi, Giuseppe Sortino, Giuseppa Fiumanò, Francesco Certo","doi":"10.23736/S0390-5616.19.04735-0","DOIUrl":"10.23736/S0390-5616.19.04735-0","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Brain tumor surgery is routinely supported by several intraoperative techniques, such as fluorescence, brain mapping and neuronavigation, which are often used independently. Efficacy of navigation is limited by the brain-shift phenomenon, particularly in cases of large or deep-sited lesions. Intraoperative imaging was introduced also to update neuronavigation data, to try and solve the brain-shift phenomenon-related pitfalls and increase overall safety. Nevertheless, each intraoperative imaging modality has some intrinsic limitations and technical shortcomings, making its clinical use challenging. We used a multimodal intraoperative imaging protocol to update neuronavigation, based on the combination of intraoperative Ultrasound (i-US) and intraoperative Computed Tomography (i-CT) integrated with 5-ALA fluorescence and neuromonitoring-guided resection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This is a pilot study on 52 patients (29 men), including four children, with a mean age of 57.67 years, suffering from brain low- (N.=10) or high-grade (N.=34) glioma or metastasis (N.=8), prospectively and consecutively enrolled. They underwent 5-ALA fluorescence-guided microsurgical tumor resection and neuromonitoring was used in cases of lesions located in eloquent areas, according to preoperative clinical and neuroradiological features. Navigated B-mode ultrasound acquisition was carried out after dural opening to identify the lesion. After tumor resection, i-US was used to identify residual tumor. Following further tumor resection or in cases of unclear US images, post-contrast i-CT was performed to detect and localize small tumor remnants and to allow further correction for brain shift. A final i-US check was performed to verify the completeness of resection. Clinical evaluation was based on comparison of pre- and postoperative Karnofsky Performance Score (KPS) and assessment of overall survival (OS) and progression-free survival (PFS). Extent of tumor resection (EOTR) was evaluated by volumetric postoperative Magnetic Resonance performed within 48 h after surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Forty-one of the 52 (78.8%) patients were alive and still under follow-up in December 2017. 5-ALA was strongly or vaguely positive in 45 cases (86.5%). Seven lesions (four low-grade glioma, one high-grade glioma, and two metastases) were not fluorescent. i-US visualized residual tumor after resection of all fluorescent or pathological tissue in 22 cases (42.3%). After i-US guided resection, i-CT documented the presence of further residual tumor in 11 cases (21.1%). Mean EOTR was 98.79% in the low-grade gliomas group, 99.84% in the high-grade gliomas group and 100% in the metastases group. KPS changed from 77.88, preoperatively, to 72.5, postoperatively. At the last follow-up, mean KPS was 84.23.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The combination of different intraoperative imaging modalities may increase brain tumor safety and extent of","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"31-43"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37153376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis. 老年原发性中枢神经系统淋巴瘤 (PCNSL) 患者的全因死亡率和肿瘤特异性死亡率趋势:监测、流行病学和最终结果 (SEER) 分析。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2019-10-08 DOI: 10.23736/S0390-5616.19.04785-4
Taylor Furst, Haydn Hoffman, Lawrence S Chin
{"title":"All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.","authors":"Taylor Furst, Haydn Hoffman, Lawrence S Chin","doi":"10.23736/S0390-5616.19.04785-4","DOIUrl":"10.23736/S0390-5616.19.04785-4","url":null,"abstract":"<p><strong>Background: </strong>Recent primary central nervous system lymphoma (PCNSL) literature indicates that younger patients benefit from improved survival; however, this benefit is not shared by those 70+ years of age. The purpose of this study was to examine mortality trends in PCNSL patients 70+ years of age to better understand why improved prognosis has not yet reached this rapidly growing population subset.</p><p><strong>Methods: </strong>Two thousand seventy-five cases (1973-2012, age at diagnosis 70+ years) within the Surveillance, Epidemiology, and End Results (SEER) database were included in Kaplan-Meier and multivariate Cox Regression analyses. Variables include age at diagnosis, decade of diagnosis (1=1973-1982, 2=1983-1992, 3=1993-2002, 4=2003-2012), sex, race and surgery.</p><p><strong>Results: </strong>Before stratification, both univariate and multivariate analyses agreed that patients aged 70-74 years at diagnosis lived the longest, while those 85+ years lived the shortest (median±SD; 6.0±0.5 months vs. 2.0±0.2 months, respectively, P<0.0005); women lived longer than men (5.0±0.3 months vs. 4.0±0.3 months, respectively, P=0.01); patients who received surgery (6.0±0.5 months) lived longer than those who did not (contraindicated=1.0±0.5 months, P<0.0005; not performed=4.0±0.3 months, P<0.0005). Univariate analysis showed decade 4 lived longer than only decade 3 (4.0±0.3 vs. 4.0±0.5, respectively, P=0.008), while multivariate analysis showed decade 4 lived longer than both 2 (5.0±0.8 months, P=0.03) and 3 (P<0.0005). Following stratification, decade and sex no longer influenced survival. Race did not influence survival.</p><p><strong>Conclusions: </strong>Minimal clinically meaningful improvements in elderly PCNSL patient all-cause and tumor-specific mortality have been made since 1973, while the best predictors of longevity include younger age and surgery.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":"1 1","pages":"44-50"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68828481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study. Pycnogenol® 可改善中风后患者的认知功能:一项为期6个月的研究。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 DOI: 10.23736/S0390-5616.22.05855-6
Gianni Belcaro, Mark Dugall, Morio Hosoi, Beatrice Feragalli, Roberto Cotellese, Aristide Saggino, Maria Rosaria Cesarone, Edmondo Ippolito, Umberto Cornelli, Andrea Ledda, David B Cox
{"title":"Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study.","authors":"Gianni Belcaro, Mark Dugall, Morio Hosoi, Beatrice Feragalli, Roberto Cotellese, Aristide Saggino, Maria Rosaria Cesarone, Edmondo Ippolito, Umberto Cornelli, Andrea Ledda, David B Cox","doi":"10.23736/S0390-5616.22.05855-6","DOIUrl":"10.23736/S0390-5616.22.05855-6","url":null,"abstract":"<p><strong>Background: </strong>This pilot study in post-stroke patients evaluated the effects of supplementation with Pycnogenol<sup>®</sup> on alterations in cognitive functions (COFU) over a period of 6 months, starting 4 weeks after the stroke.</p><p><strong>Methods: </strong>The effects of supplementation - possibly acting on residual brain edema, on global cognitive function, attention and on mental performance - were studied. A control group used standard management (SM) and the other group added Pycnogenol<sup>®</sup>, 150 mg daily to SM.</p><p><strong>Results: </strong>38 post-stroke patients completed the 6-month-study, 20 in the Pycnogenol<sup>®</sup> group and 18 in the control group. No side effects were observed with the supplement. The tolerability was very good. The patients included into the two groups were comparable for age, sex and clinical distribution. There were 2 dropouts in the control group, due to non-medical problems. Main COFU parameters (assessed by a cognitive questionnaire) were significantly improved (all single items) with the supplement compared to controls (P<0.05). Additional observations indicate that Pycnogenol<sup>®</sup> patients experienced significantly less mini-accidents (including falls) than controls (P<0.05). The incidences of (minor) psychotic episodes or conflicts and distress and other problems including rare occurrence of minor hallucinations, were lower with the supplementation than in controls (P<0.05). Single observations concerning daily tasks indicated a better effect of Pycnogenol<sup>®</sup> compared to controls (P<0.05). Plasma free radicals also decreased significantly with the supplement in comparison to controls (P<0.05). Globally, supplemented subjects had a better recovery than controls.</p><p><strong>Conclusions: </strong>In post-stroke subjects, Pycnogenol<sup>®</sup> supplementation resulted in better recovery outcome and faster COFU 'normalization' after the stroke in comparison with SM; it can be considered a safe, manageable post-stroke, adjuvant management possibly reducing local brain edema. Nevertheless, more patients and a longer period of evaluation are needed to confirm these results.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":"68 1","pages":"109-116"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139650923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visualization of volume of tissue activated modeling in a clinical planning system for deep brain stimulation. 脑深部刺激临床规划系统中组织激活建模体积的可视化。
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2020-02-04 DOI: 10.23736/S0390-5616.19.04827-6
Barbara Carl, Miriam Bopp, Benjamin SAß, Josefine Waldthaler, Lars Timmermann, Christopher Nimsky
{"title":"Visualization of volume of tissue activated modeling in a clinical planning system for deep brain stimulation.","authors":"Barbara Carl, Miriam Bopp, Benjamin SAß, Josefine Waldthaler, Lars Timmermann, Christopher Nimsky","doi":"10.23736/S0390-5616.19.04827-6","DOIUrl":"10.23736/S0390-5616.19.04827-6","url":null,"abstract":"<p><strong>Background: </strong>Pathway activating models try to describe stimulation spread in deep brain stimulation (DBS). Volume of tissue activated (VTA) models are simplified model variants allowing faster and easier computation. Our study aimed to investigate, how VTA visualization can be integrated into a clinical workflow applying directional electrodes using a standard clinical DBS planning system.</p><p><strong>Methods: </strong>Twelve patients underwent DBS, using directional electrodes for bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease. Preoperative 3T magnetic resonance imaging was used for automatic visualization of the STN outline, as well as for fiber tractography. Intraoperative computed tomography was used for automatic lead detection. The Guide XT software, closely integrated into the DBS planning software environment, was used for VTA calculation and visualization.</p><p><strong>Results: </strong>VTA visualization was possible in all cases. The percentage of VTA covering the STN volume ranged from 25% to 100% (mean: 60±25%) on the left side and from 0% to 98% (51±30%) on the right side. The mean coordinate of all VTA centers was: 12.6±1.2 mm lateral, 2.1±1.2 mm posterior, and 2.3±1.4 mm inferior in relation to the midcommissural point. Stimulation effects can be compared to the VTA visualization in relation to surrounding structures, potentially facilitating programming, which might be especially beneficial in case of suboptimal lead placement.</p><p><strong>Conclusions: </strong>VTA visualization in a clinical planning system allows an intuitive adjustment of the stimulation parameters, supports programming, and enhances understanding of effects and side effects of DBS.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"59-69"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37619994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of percutaneous kyphoplasty combined with zoledronic acid injection on osteoporotic vertebral compression fracture and bone metabolism indices. 经皮椎体成形术联合唑来膦酸注射对骨质疏松性脊椎压缩骨折和骨代谢指数的影响
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2020-12-09 DOI: 10.23736/S0390-5616.20.05117-6
Hongchi Yi, Tao Chen, Jiming Gan, Zhuoqian Dong, Dun Liu, Yuanzhi Zheng, Huijun Ning, Qingzhong Wei
{"title":"Effects of percutaneous kyphoplasty combined with zoledronic acid injection on osteoporotic vertebral compression fracture and bone metabolism indices.","authors":"Hongchi Yi, Tao Chen, Jiming Gan, Zhuoqian Dong, Dun Liu, Yuanzhi Zheng, Huijun Ning, Qingzhong Wei","doi":"10.23736/S0390-5616.20.05117-6","DOIUrl":"10.23736/S0390-5616.20.05117-6","url":null,"abstract":"<p><strong>Background: </strong>Osteoporotic vertebral compression fracture (OVCF) is usually treated by percutaneous kyphoplasty (PKP) which has limitations. We aimed to evaluate the effects of PKP combined with zoledronic acid (ZOL) injection on OVCF and bone metabolism indices.</p><p><strong>Methods: </strong>A total of 600 OVCF patients admitted from June 2015 to June 2020 were randomly divided into group A (PKP alone), group B (PKP combined with ZOL 1 month later) and group C (PKP concurrently combined with ZOL) (N.=200). Before as well as 1 month (before ZOL treatment in group B) and 1 year after PKP, the pain degree, physical function and self-care ability in daily life were assessed, the height and kyphosis Cobb angle of vertebral body with compression fracture and bone mineral densities (BMDs) at different parts were measured, the clinical efficacy, adverse reactions and recurrence of vertebral fractures during 3 years of follow-up were observed, and the serum levels of BAP, BGP, β-CTx and TP1NP were detected.</p><p><strong>Results: </strong>Compared with groups A and B, group C had significantly reduced visual analogue scale (VAS) and Oswestry disability index (ODI) scores and raised activity of daily living (ADL) score 1 month after PKP (P<0.05). Groups A-C had successively lowered VAS and ODI scores and elevated ADL Score 1 year after PKP (P<0.05). Compared with before PKP, the height of vertebral body with compression fracture significantly increased, and the kyphosis Cobb angle decreased in the three groups 1 month and 1 year after PKP (P<0.05). In group A, the height was lower whereas the angle was larger 1 year after PKP than those 1 month after PKP (P<0.05). One month after PKP, the height was significantly higher and the angle was smaller in group C than those of groups A and B (P<0.05). One year after PKP, the height significantly increased and the angle decreased successively in groups A-C (P<0.05). BMDs at different parts were significantly higher in group C than those of groups A and B 1 month after PKP (P<0.05). One year after PKP, BMDs were highest in group C and lowest in group A (P<0.05). The overall response rate was significantly higher in group C than that in group A (P<0.05). The recurrence rate of fractures was significantly higher in group A than those of groups B and C (P<0.05). The BAP, BGP, β-CTx and TP1NP levels were significantly lower in group C than those of groups A and B 1 month after PKP (P<0.05), and declined successively in groups A-C 1 year after PKP (P<0.05).</p><p><strong>Conclusions: </strong>PKP concurrently combined with ZOL exert the most significant therapeutic effects on OVCF, with the lowest recurrence rate of fractures. It relieves pain and improves the physical function and self-care ability in daily life probably by reducing bone metabolism indices, increasing BMD, and maintaining the height and kyphosis Cobb angle of recovered vertebral body.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"80-88"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38691543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant calcified thoracic disk herniations: ossification of PLL or autonomous entity? 巨型钙化胸椎椎间盘突出症:PLL 的骨化还是独立实体?
IF 1.9 4区 医学
Journal of neurosurgical sciences Pub Date : 2024-02-01 Epub Date: 2020-07-29 DOI: 10.23736/S0390-5616.20.04938-3
Giuseppe D'Aliberti, Fabio Villa, Pietro Giorgi, Francesco M Crisà, Giulia Gribaudi, Lara Mastino, Anna M Auricchio, Marco Cenzato, Giuseppe Talamonti
{"title":"Giant calcified thoracic disk herniations: ossification of PLL or autonomous entity?","authors":"Giuseppe D'Aliberti, Fabio Villa, Pietro Giorgi, Francesco M Crisà, Giulia Gribaudi, Lara Mastino, Anna M Auricchio, Marco Cenzato, Giuseppe Talamonti","doi":"10.23736/S0390-5616.20.04938-3","DOIUrl":"10.23736/S0390-5616.20.04938-3","url":null,"abstract":"<p><strong>Background: </strong>Giant calcified thoracic disk herniation (GCTD) is an uncommon event, which requires surgical treatment in less than 1% of patients. GCDTs are a specific subgroup of herniated thoracic disks occupying more than 40% of the spinal canal showing calcifications associated with a certain degree of ossification. In this paper, we are reporting our whole experience in the surgical management of GCTDs through anterior approaches. We believe that they present characteristics that associate them to the circumscribed type of ossified posterior longitudinal ligament (OPLL) with a possible common pathophysiology consisting in the dural violation.</p><p><strong>Methods: </strong>Twenty-three consecutive patients with GCDTs were managed through anterior approaches during the period 1996-2019 at the Niguarda Hospital, Milan, Italy. Clinical data, radiological features, surgical reports, histological findings, and outcomes were reviewed.</p><p><strong>Results: </strong>There was no mortality, whereas permanent morbidity consisted of 1 case of worsened paraparesis due to accidental spinal cord contusion. One patient required reoperation to repair a postoperative cerebrospinal fluid (CSF) leakage. All patients underwent postoperative MRI which showed excellent decompression of cord and dural sac in all cases. Histological study of en-bloc removed GCTD showed typical calcification patterns of the PLL.</p><p><strong>Conclusions: </strong>GCDTs may be assimilated to the so-called \"circumscribed type\" of OPLL. The GCDTs may show the same radiological CT and MRI pattern of OPLL. The anterior accesses now represent the standard of care for GCTDs. The use of operative microscope and intraoperative monitoring is mandatory. The risk of CSF leakage can be markedly reduced by meticulous reconstruction of the dura and the placement of spinal drainage. Adequate exposition may sometimes require one or two levels of corpectomy with consequent vertebral body reconstruction and fixation of anterior column of the spine.</p>","PeriodicalId":16504,"journal":{"name":"Journal of neurosurgical sciences","volume":" ","pages":"70-79"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38211574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信